Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive zonisamide for partial seizures (multicenter, placebo-controlled, double-blind)
2016-004951-55Phase 3
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Zonisamide + background AEDs with Placebo + background AEDs (2 arms). Primary endpoint: Median percent change in all partial seizure frequency during fixed-dose phase.
02
Drugs
zonisamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2016-004951-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004951-55.